Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Digital & Data,Drug Discovery & Development

    Retab launches developer-first document AI platform and raises $3.5M in pre-seed funding

    Retab, a startup aiming to simplify document automation for developers, [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    Cytovale’s IntelliSep rapid sepsis test boosts ED discharges by 56% while maintaining patient safety

    A new multicenter study shows Cytovale’s rapid sepsis test IntelliSep [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    FDA grants fast track to Nektar’s rezpegaldesleukin for severe alopecia areata

    Nektar Therapeutics has received FDA Fast Track designation for its [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Centauri Therapeutics secures $5.1M from CARB-X to advance ABX-01 to first-in-human trials

    Centauri aims to start first-in-human clinical study for broad-spectrum immunotherapy [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Ofichem expands drug substance capabilities with acquisition of Meribel Pharma Solutions’ Uppsala site in Sweden

    Acquisition enhances innovation offering and expands biotech footprint across Nordic [...]

    May 5, 2026
  • Drug Discovery & Development

    New England Biolabs launches low-bias small RNA library prep kit to improve RNA sequencing accuracy

    New England Biolabs (NEB) has introduced the NEBNext Low-bias Small [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Cytovale’s IntelliSep test drives 56% rise in safe ED discharges, easing pressure on hospital beds

    A new multicenter study has found that a rapid blood [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events

    Pharma’s digital reckoning: Why SEO is now a strategic imperative

    With growing debate over a potential ban on DTC TV [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    AltPep data highlights potential of intranasal peptide for early-stage Alzheimer’s

    AltPep Corporation has presented new preclinical findings at the Alzheimer’s [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    MHRA approves Biogen’s tofersen for ultra-rare genetic form of motor neurone disease

    The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has [...]

    May 5, 2026
Previous606162Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Verdiva Bio starts Phase 1 trial of once-weekly oral amylin drug for obesity
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development
  • Clean Cells acquires Anaquant to expand mass spectrometry capabilities in biopharma quality control
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Research & Development
  • AB2 Bio receives $30 million as Nippon Shinyaku exercises US option for rare disease drug
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top